J Michael Dixon Selected Research

J Michael Dixon Research Topics

Disease

77	Breast Neoplasms (Breast Cancer) 01/2023 - 01/2002
61	Neoplasms (Cancer) 10/2023 - 01/2002
6	Neoplasm Metastasis (Metastasis) 11/2020 - 05/2006
5	Noninfiltrating Intraductal Carcinoma (DCIS) 11/2017 - 08/2007
3	Margins of Excision 01/2023 - 12/2010
3	Lobular Carcinoma 01/2018 - 12/2011
2	Triple Negative Breast Neoplasms 03/2024 - 12/2015
2	Disease Progression 01/2021 - 07/2006
1	COVID-19 01/2020
1	Insulin Resistance 01/2019
1	Obesity 01/2019
1	Inflammatory Breast Neoplasms 12/2018
1	Erythema 12/2018
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 11/2018
1	Pathologic Complete Response 06/2017
1	Hypoxia (Hypoxemia) 09/2015
1	Carcinoma (Carcinomatosis) 09/2015
1	Thymoma (Thymic Carcinoma) 03/2015
1	Ductal Carcinoma 10/2014
1	Asthenia 08/2013
1	Procedural Pain 08/2013
1	Nausea 08/2013
1	Bone Resorption 02/2010

Drug/Important Bio-Agent (IBA)

31	Estrogen ReceptorsIBA 01/2022 - 01/2002
23	Letrozole (Femara)FDA LinkGeneric 01/2020 - 06/2002
23	Tamoxifen FDA LinkGeneric 01/2012 - 01/2002
21	Aromatase InhibitorsIBA 01/2019 - 06/2002
16	Hormones (Hormone)IBA 01/2023 - 01/2002
14	Estrogens (Estrogen)FDA Link 01/2017 - 06/2002
14	Anastrozole (Arimidex)FDA LinkGeneric 03/2013 - 06/2002
12	Biomarkers (Surrogate Marker)IBA 10/2021 - 01/2004
6	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 07/2008
6	exemestane (Aromasin)FDA Link 01/2020 - 03/2002
5	Aromatase (CYP19)IBA 01/2019 - 06/2002
4	Everolimus FDA Link 01/2013 - 06/2009
3	RNA (Ribonucleic Acid)IBA 01/2022 - 02/2008
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 08/2009
3	Fulvestrant (Faslodex)FDA Link 01/2020 - 03/2013
3	Progesterone Receptors (Progesterone Receptor)IBA 12/2015 - 04/2005
3	Estradiol (Delestrogen)FDA LinkGeneric 08/2012 - 04/2008
2	CytokinesIBA 10/2021 - 06/2021
2	Cytokine Receptor gp130IBA 10/2021 - 06/2021
2	Phenobarbital (Luminal)FDA Link 05/2021 - 07/2011
2	Cadherins (E-Cadherin)IBA 01/2021 - 10/2014
2	human ERBB2 proteinIBA 01/2019 - 08/2005
2	Messenger RNA (mRNA)IBA 01/2017 - 05/2014
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2017 - 04/2005
2	Estrogen Receptor alphaIBA 07/2015 - 12/2006
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2013 - 04/2010
2	ClaudinsIBA 03/2011 - 08/2009
2	Estrone FDA Link 01/2010 - 04/2008
2	Gonadotropin-Releasing Hormone (GnRH)FDA Link 02/2009 - 01/2002
1	Insulin-Like Growth Factor I (IGF-1)IBA 02/2022
1	Conditioned Culture MediaIBA 08/2021
1	palbociclibIBA 05/2021
1	Ado-Trastuzumab EmtansineIBA 05/2021
1	neratinibIBA 05/2021
1	SteroidsIBA 01/2021
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2021
1	AZD9496IBA 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	Aromatase deficiencyIBA 01/2019
1	Insulin (Novolin)FDA Link 01/2019
1	LeptinIBA 01/2019
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 11/2018
1	Epidermal Growth Factor (EGF)IBA 01/2017
1	NeuregulinsIBA 01/2017
1	LigandsIBA 01/2017
1	Neuregulin-1 (Neuregulin 1)IBA 01/2017
1	Estrogen Receptor Modulators (Antiestrogen)IBA 12/2015
1	sulfamic acid (ammonium sulfamate)IBA 09/2015
1	Carbonic Anhydrase IXIBA 09/2015
1	olaparibIBA 08/2013
1	Capsules (Microcapsules)IBA 08/2013
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 08/2013
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 08/2013
1	CreatinineIBA 08/2013
1	Holliday Junction ResolvasesIBA 03/2013
1	estrone sulfate (Evex)FDA Link 08/2012
1	CollagenIBA 01/2012
1	Phosphotransferases (Kinase)IBA 02/2011
1	Eukaryotic Initiation Factor-4EIBA 02/2011
1	Sirolimus (Rapamycin)FDA Link 02/2011
1	Cell-Free Nucleic AcidsIBA 04/2010
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 03/2010
1	Celecoxib (Celebrex)FDA Link 03/2010
1	EnzymesIBA 01/2010

Therapy/Procedure

59	Therapeutics 10/2023 - 01/2002
21	Neoadjuvant Therapy 11/2020 - 03/2002
11	Radiotherapy 01/2023 - 05/2006
10	Drug Therapy (Chemotherapy) 03/2024 - 01/2002
9	Segmental Mastectomy (Lumpectomy) 01/2023 - 01/2004
7	Mastectomy (Mammectomy) 10/2019 - 01/2004
4	Adjuvant Chemotherapy 01/2020 - 08/2008
1	Lasers (Laser) 02/2022
1	Contraindications 12/2018
1	Breast Implants (Breast Implant) 11/2018
1	Immunotherapy 12/2015
1	Aftercare (After-Treatment) 09/2015
1	Mammaplasty (Breast Reconstruction) 09/2012